24 related articles for article (PubMed ID: 38561063)
1. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine.
Daulton E; Wicaksono AN; Tiele A; Kocher HM; Debernardi S; Crnogorac-Jurcevic T; Covington JA
Talanta; 2021 Jan; 221():121604. PubMed ID: 33076134
[TBL] [Abstract][Full Text] [Related]
2. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
[TBL] [Abstract][Full Text] [Related]
3. A Complete Pipeline for Untargeted Urinary Volatolomic Profiling with Sorptive Extraction and Dual Polar and Nonpolar Column Methodologies Coupled with Gas Chromatography Time-of-Flight Mass Spectrometry.
Wen Q; Myridakis A; Boshier PR; Zuffa S; Belluomo I; Parker AG; Chin ST; Hakim S; Markar SR; Hanna GB
Anal Chem; 2023 Jan; 95(2):758-765. PubMed ID: 36602225
[TBL] [Abstract][Full Text] [Related]
4. Volatolomic approach by HS-SPME/GC-MS and chemometric evaluations for the discrimination of X-ray irradiated mozzarella cheese.
Zianni R; Mentana A; Tomaiuolo M; Campaniello M; Iammarino M; Centonze D; Palermo C
Food Chem; 2023 Oct; 423():136239. PubMed ID: 37182488
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air.
Princivalle A; Monasta L; Butturini G; Bassi C; Perbellini L
BMC Cancer; 2018 May; 18(1):529. PubMed ID: 29728093
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
7. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening.
Zhang Z; Qin W; Sun Y
Pathol Res Pract; 2018 Dec; 214(12):1923-1928. PubMed ID: 30477640
[TBL] [Abstract][Full Text] [Related]
8. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
[TBL] [Abstract][Full Text] [Related]
9. Volatile organic compounds analysis as promising biomarkers for Parkinson's disease diagnosis: A systematic review and meta-analysis.
Habibzadeh A; Ostovan VR; Keshavarzian O; Kardeh S; Mahmoudi SS; Zakeri MR; Tabrizi R
Clin Neurol Neurosurg; 2023 Dec; 235():108022. PubMed ID: 37939618
[TBL] [Abstract][Full Text] [Related]
10. Nanoscale Sensor Technologies for Disease Detection via Volatolomics.
Vishinkin R; Haick H
Small; 2015 Dec; 11(46):6142-64. PubMed ID: 26448487
[TBL] [Abstract][Full Text] [Related]
11. Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis.
Martínez-Moral MP; Tena MT; Martín-Carnicero A; Martínez A
Clin Chim Acta; 2024 Apr; 557():117895. PubMed ID: 38561063
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
